Tools in polypharmacy: Current evidence from observational and controlled studies;Werkzeuge im Umgang mit Polypharmazie: Aktuelle Evidenz aus kontrollierten- und Beobachtungsstudien

Zeitschrift fur Gerontologie und Geriatrie

Volumn 45, Issue 6, 2012, Pages 468-472

  Dovjak, Peter ^a  

^a Landeskrankenhaus Gmunden ^*  (Austria)

Author keywords

Adverse drug events; Drug interactions; Geriatrics; Patient adherence; Polypharmacy

Indexed keywords

AGED; ALGORITHM; ARTICLE; CONTROLLED CLINICAL TRIAL (TOPIC); DRUG INTERACTION; DRUG TOXICITY; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; INAPPROPRIATE PRESCRIBING; INCIDENCE; MALE; POLYPHARMACY; RISK ASSESSMENT; RISK FACTOR; STATISTICS;

AGED; AGED, 80 AND OVER; ALGORITHMS; CONTROLLED CLINICAL TRIALS AS TOPIC; DRUG INTERACTIONS; DRUG TOXICITY; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; INAPPROPRIATE PRESCRIBING; INCIDENCE; MALE; POLYPHARMACY; RISK ASSESSMENT; RISK FACTORS;

EID: 84865802524     PISSN: 09486704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00391-012-0362-y     Document Type: Article

References (31)

1. Bain KT, Holmes HM, Beers MH et al (2008) Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process. J Am Geriatr Soc 56:1946-1952
2. Barry PJ, Gallagher P, Ryan C et al (2007) START (screening tool to alert doctors to the right treatment)an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing 36:632-638
3. Campanielli CM (2012) The American Geriatrics Society. American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 60:616-631
4. Carey EC, Covinsky KE, Lui LY et al (2008) Prediction of mortality in community-living frail elderly people with long-term care needs. J Am Geriatr Soc 56:68-75
5. Chumney EC, Robinson LC (2006) The effect of pharmacist interventions on patients with polyphamacy. Pharm Pract 4:103-109
6. Dovjak P, Sommeregger U, Otto R et al (2010) Polypharmazie in der Kardiologie-ein beachtliches Problem bei Synkopen, QT-Zeit-Verlangerung, Bradykardie und Tachykardie. Wien Med Wochenzeitschr 160:264-69
7. Elsawy B, Higgins KE (2011) The geriatric assessment. Am Fam Physician 83:48-56
8. Gallagher P, O'Mahony D (2008) STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beer's criteria. Age Ageing 37:673-679
9. Gandhi TK, Weingart SN, Borus J et al (2003) Adverse drug events in ambulatory care. N Engl J Med 16:1556-1564
10. Gosch M, Böhmdorfer B, Benvenuti Falger U et al (2010) Polypharmazie und Schmerztherapie. Wien Med Wochenzeitschr 160:286-292
11. Hanlon JT, Schmader KE, Koronkowski MJ et al (1997) Adverse drug events in high risk older outpatients. J Am Geriatr Soc 370:185-191
12. Hanlon JT, Schmader KE, Samsa GP et al (1992) A method for assessing drug therapy appropriateness. J Clin Epidem 45:1045-1051
13. Hauptverband der österreichischen Sozialversicherungsträger (2012) Die österreichische Sozialversicherung in Zahlen. Available at: http://www.sozialversicherung.at. Accessed 20 June 2012
14. Holt S, Schmiedl S, Thürmann PA (2010) Potentiell inadäquate Medikation für ältere Menschen: Die PRISCUS Liste. Dtsch Ärztebl 107:543-551
15. Hovstadius B, Astrand B, Petersson G (2010) Assessment of regional variation in polypharmacy. Pharmocoepidemiol Drug Saf 19:375-383
16. Iglseder B, Dovjak P, Benvenuti-Falger U et al (2010) Medikamenten-induzierte Delirien älterer Menschen, Wien Med Wochenzeitschr 160:281-285
17. LaMantia MA, Scheunemann LP, Viera AJ et al (2010) Interventions to improve transitional care between nursing homes and hospitals: a systematic review. J Am Geriatr Soc 58:777-782
18. Mann E, Böhmdorfer B, Frühwald T et al (2012) Potentially inappropriate medication in geriatric patients: the Austrian consensus panel list. Wien Klin Wochenschr 124:160-169
19. Naranjo CA, Busto U, Sellers EM et al (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239-245
20. Onder G, Petrovic M, Tangiisuran B et al (2010) Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years of older. Arch Intern Med 170:1142-1148
21. Osterberg L, Blaschke T (2005) Adherence to Medication. N Engl J Med 353:487-497
22. Scott IA, Gray LC, Martin JH et al (2012) Minimizing inappropriate medication in older populations: a ten-step conceptual framework. Am J Med 125:529-537
23. Sommeregger U et al (2011) Österreichisches Geriatrisches Basisassessment. Österreichische Gesellschaft für Geriatrie und Geronotologie, Apollogasse 19,1070 Wien
24. Sommeregger U, Iglseder B, Böhmdorfer B et al (2010) Polypharmazie und Stürze im Alter. Wien Med Wochenzeitschr 160:293-296
25. Spinewine A, Schmader KE, Barber N et al (2007) Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 370:173-84
26. Steinman MA, Handler SM, Gurwitz JH et al (2011) Beyond the prescription: medication monitoring and adverse drug events in older adults. J Am Geriatr Soc 59:1513-1520
27. Steinman MA, Hanlon JT (2010) Managing medication in clinically complex elders. JAMA 304:1592-1601
28. Studenski S, Perera S, Patel K et al (2011) Gait speed and survival in older adults. JAMA 305:50-58
29. Vass M, Hendriksen C (2005) Polypharmacy and older people. Z Gerontol Geriatr 38(Suppl 1):I/14-I/17
30. Williams A, Manias E, Walker R (2008) Interventions to improve medication adherence in people with multiple chronic conditions: a systematic review. J Adv Nurs 63:132-143
31. Woodard LD, Landrum CR, Urech TH et al (2012) Treating chronically ill people with diabetes mellitus with limited life expectancy; implications for performance measurement. J Am Geriatr Soc 60:193-201